CCCA Alopecia: Causes, Diagnosis & Treatment Options

What Is CCCA Alopecia?

Central centrifugal cicatricial alopecia (CCCA) is a type of scarring hair loss that starts at the crown or center of the scalp and spreads outward. Unlike common pattern baldness, CCCA destroys the hair follicle permanently, replacing it with scar tissue. It's most common in women of African descent, though it can affect anyone. Because the follicles are destroyed, early diagnosis is critical—once scarring occurs, hair cannot regrow in those areas.

CCCA is considered a lymphocytic scarring alopecia, meaning the inflammation is primarily driven by lymphocytes attacking the hair follicle. This distinguishes it from other types of scarring alopecia and influences treatment choices. The condition often progresses slowly, which can make it easy to miss in the early stages. Many people attribute the initial thinning to stress, aging, or poor hair care, delaying the specialist evaluation that could save their remaining hair.

Causes and Risk Factors

The exact cause of CCCA isn't fully understood, but research points to a combination of genetic and environmental factors. It often runs in families, and certain hair care practices may trigger or worsen it. Inflammation around the hair follicle is believed to play a central role in the scarring process. Recent studies have identified mutations in genes that regulate the hair follicle cycle, suggesting a genetic predisposition in many cases.

Hair care practices are a major focus of research. Tight braids, weaves, and extensions can create constant tension on the scalp, leading to inflammation and eventually scarring. Chemical relaxers and heat styling can also damage the follicle. However, not everyone who uses these practices develops CCCA, which is why genetics are thought to play a significant role. Underlying inflammatory conditions, such as autoimmune diseases, may also contribute.

• Genetic predisposition—family history significantly increases risk.
• Frequent use of tight hairstyles (braids, weaves, extensions) that pull on the scalp.
• Chemical treatments and heat styling that damage the follicle.
• Underlying inflammatory or autoimmune conditions.
• More common in women, especially those of African ancestry, often starting in the 30s or 40s.

Symptoms and Stages

CCCA usually begins with subtle thinning at the crown. Many people notice widening of the part or a small bald spot that gradually expands. Itching, tenderness, or a burning sensation may occur early on. As the condition progresses, the scalp in affected areas may look smooth and shiny, and hair follicles become less visible. In advanced stages, the scalp may appear scarred and feel tight.

The progression of CCCA is typically divided into three stages: early, moderate, and advanced. In the early stage, inflammation is present but scarring is minimal. This is the best window for treatment because follicles are still alive, though inflamed. In the moderate stage, some follicles have been destroyed, and the bald patch becomes more noticeable. In the advanced stage, extensive scarring has occurred, and the scalp is smooth and shiny with no visible follicles.

• Early stage: mild thinning at the crown, possible itching or tenderness.
• Moderate stage: noticeable bald patch spreading outward, reduced follicle density.
• Advanced stage: extensive scarring, smooth scalp, permanent hair loss.

How CCCA Is Diagnosed

Diagnosis typically involves a dermatologist examining your scalp and medical history. Because CCCA can mimic other types of hair loss, a scalp biopsy is often the definitive test. Dermoscopy (a magnified view of the scalp) can also help identify characteristic features like loss of follicular openings. Your dermatologist may also ask about your hair care routine, family history, and any symptoms like itching or tenderness.

A scalp biopsy involves removing a small sample of scalp tissue, usually about 4mm in diameter, and examining it under a microscope. This can confirm the presence of inflammation and scarring and rule out other conditions like alopecia areata or traction alopecia. Blood tests may be ordered to check for underlying conditions such as thyroid disorders, iron deficiency, or autoimmune diseases that could contribute to hair loss.

• Clinical examination of the scalp and pattern of hair loss.
• Dermoscopy to check for follicular dropout and perifollicular scaling.
• Scalp biopsy to confirm scarring and rule out other conditions.
• Blood tests to exclude thyroid issues, iron deficiency, or autoimmune diseases.

Treatment Options for CCCA

There is no cure for CCCA, but treatment aims to control inflammation, slow progression, and preserve remaining hair. Options range from topical medications to procedural therapies. The earlier treatment starts, the better the outcome. Treatment plans are often tailored to the stage of the condition and the patient's response to initial therapies.

Topical corticosteroids are often the first line of treatment for mild cases. They reduce inflammation and can help slow the progression of scarring. Minoxidil, available in topical or oral forms, may be used to stimulate remaining follicles. Platelet-rich plasma (PRP) injections are an emerging option that involves injecting concentrated platelets from your own blood into the scalp to promote healing and hair growth. Oral antibiotics or anti-inflammatory medications may be prescribed for severe or progressive cases.

• Topical corticosteroids to reduce inflammation.
• Minoxidil (topical or oral) to stimulate remaining follicles.
• Finasteride—sometimes used off-label in women, but not standard for CCCA.
• Platelet-rich plasma (PRP) injections to promote healing and hair growth.
• Oral antibiotics or anti-inflammatory medications for severe cases.
• Avoidance of tight hairstyles and harsh chemicals.

Is a Hair Transplant Suitable for CCCA?

Hair transplants are generally not recommended for active CCCA because the underlying inflammation can destroy transplanted follicles. However, if the condition has been stable for a prolonged period (often at least 1–2 years) and inflammation is controlled, a transplant may be considered to fill in scarred areas. The success rate is lower than in non-scarring alopecia, and careful patient selection is essential.

Before considering a transplant, your dermatologist will likely perform a scalp biopsy to confirm that inflammation has subsided. Even with a stable condition, graft survival rates may be lower than in patients with pattern baldness. It's important to have realistic expectations and to continue medical therapy after surgery to protect remaining hair. A transplant should be part of a comprehensive treatment plan, not a standalone solution.

• Only consider transplant if CCCA has been inactive for at least a year.
• A scalp biopsy may be required to confirm inflammation has subsided.
• Expect lower graft survival rates compared to pattern baldness.
• Combine surgery with ongoing medical therapy to protect remaining hair.

What to Expect from Treatment: Timeline and Monitoring

Treatment response varies. Inflammation control may take several months, and hair regrowth (if any) is slow. Regular follow-ups with your dermatologist are important to adjust therapy and monitor for progression. Photographs and dermoscopy help track changes objectively. It's also helpful to keep a journal of symptoms and any side effects from medications.

Initial improvement in symptoms like itching and tenderness may be noticed within 4–8 weeks of starting treatment. However, visible changes in hair density may take 6–12 months. Ongoing monitoring every 3–6 months is typical to assess stability and adjust treatment as needed. CCCA management is a long-term commitment, and patience is key. Some patients may need to try several treatments before finding the one that works best for them.

• Initial improvement in symptoms (itching, tenderness) within 4–8 weeks.
• Visible changes in hair density may take 6–12 months.
• Ongoing monitoring every 3–6 months to assess stability.
• Be patient—CCCA management is a long-term commitment.

Frequently Asked Questions